Published in Philos Trans R Soc Lond B Biol Sci on June 29, 2004
Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond B Biol Sci (2009) 3.40
Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc Natl Acad Sci U S A (2007) 2.14
Evolutionary medicine: its scope, interest and potential. Proc Biol Sci (2012) 1.94
Inferred relatedness and heritability in malaria parasites. Proc Biol Sci (2010) 1.69
Immunity promotes virulence evolution in a malaria model. PLoS Biol (2004) 1.69
Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet (2009) 1.66
The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol (2012) 1.61
Superinfection drives virulence evolution in experimental populations of bacteria and plasmids. Evolution (2010) 1.57
Virulence-transmission trade-offs and population divergence in virulence in a naturally occurring butterfly parasite. Proc Natl Acad Sci U S A (2008) 1.57
Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol (2006) 1.55
The great opportunity: Evolutionary applications to medicine and public health. Evol Appl (2008) 1.43
Virulence evolution in response to vaccination: the case of malaria. Vaccine (2008) 1.40
Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data. PLoS One (2012) 1.36
Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei. Nature (2013) 1.34
Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am J Trop Med Hyg (2006) 1.33
Controlling and coordinating development in vector-transmitted parasites. Science (2011) 1.29
Common inheritance of chromosome Ia associated with clonal expansion of Toxoplasma gondii. Genome Res (2006) 1.28
Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates. PLoS Pathog (2009) 1.24
Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger. Malar J (2009) 1.19
Epidemiological, evolutionary, and coevolutionary implications of context-dependent parasitism. Am Nat (2011) 1.18
From silent genes to noisy populations-dialogue between the genotype and phenotypes of antigenic variation. J Eukaryot Microbiol (2007) 1.16
A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. J Med Chem (2006) 1.13
The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference. Proc Biol Sci (2008) 1.12
Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity. Mol Biol Evol (2014) 1.11
Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evol Biol (2008) 1.04
Behavioral Immunity in Insects. Insects (2012) 1.02
Evolution in health and medicine Sackler colloquium: Evolutionary perspectives on health and medicine. Proc Natl Acad Sci U S A (2010) 1.02
The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat (2009) 1.01
Fitness costs of disrupting circadian rhythms in malaria parasites. Proc Biol Sci (2011) 1.00
Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children. PLoS Negl Trop Dis (2012) 0.98
Strength in numbers: high parasite burdens increase transmission of a protozoan parasite of monarch butterflies (Danaus plexippus). Oecologia (2009) 0.98
The relationship of within-host multiplication and virulence in a plant-virus system. PLoS One (2007) 0.98
Integrating life history and cross-immunity into the evolutionary dynamics of pathogens. Proc Biol Sci (2006) 0.95
Mixed allele malaria vaccines: host protection and within-host selection. Vaccine (2008) 0.94
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms. Nat Rev Genet (2015) 0.93
Parasite-driven pathogenesis in Trypanosoma brucei infections. Parasite Immunol (2011) 0.92
Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One (2009) 0.92
Investigating the evolution of apoptosis in malaria parasites: the importance of ecology. Parasit Vectors (2010) 0.89
Influence of vectors' risk-spreading strategies and environmental stochasticity on the epidemiology and evolution of vector-borne diseases: the example of Chagas' disease. PLoS One (2013) 0.86
Hepatic miRNA expression reprogrammed by Plasmodium chabaudi malaria. Parasitol Res (2010) 0.85
Immune-mediated competition in rodent malaria is most likely caused by induced changes in innate immune clearance of merozoites. PLoS Comput Biol (2014) 0.81
Comparison of genomic signatures of selection on Plasmodium falciparum between different regions of a country with high malaria endemicity. BMC Genomics (2015) 0.81
The separate and combined effects of MHC genotype, parasite clone, and host gender on the course of malaria in mice. BMC Genet (2006) 0.80
Mosquito transmission, growth phenotypes and the virulence of malaria parasites. Malar J (2013) 0.80
Testing Local Adaptation in a Natural Great Tit-Malaria System: An Experimental Approach. PLoS One (2015) 0.79
Avian malaria: a new lease of life for an old experimental model to study the evolutionary ecology of Plasmodium. Philos Trans R Soc Lond B Biol Sci (2015) 0.79
How selection forces dictate the variant surface antigens used by malaria parasites. J R Soc Interface (2011) 0.79
Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. Proc Biol Sci (2016) 0.79
Genetic polymorphism of merozoite surface protein-1 in Plasmodium falciparum isolates from patients with mild to severe malaria in Libreville, Gabon. Parasite (2015) 0.79
Case-control approach to identify Plasmodium falciparum polymorphisms associated with severe malaria. PLoS One (2009) 0.78
Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria. Proc Biol Sci (2016) 0.78
Beyond Mortality: Sterility As a Neglected Component of Parasite Virulence. PLoS Pathog (2015) 0.77
Revealing mechanisms underlying variation in malaria virulence: effective propagation and host control of uninfected red blood cell supply. J R Soc Interface (2012) 0.77
Opportunities and challenges of Integral Projection Models for modelling host-parasite dynamics. J Anim Ecol (2015) 0.77
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model. Malar J (2015) 0.76
Bimodal transmission of cerebral malaria and severe malarial anemia and reciprocal co-existence of sexual and asexual parasitemia in an area of seasonal malaria transmission. Parasitol Res (2008) 0.76
The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine. Parasitology (2016) 0.76
Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population. Malar J (2016) 0.75
Simplified Reversed Chloroquines To Overcome Malaria Resistance to Quinoline-Based Drugs. Antimicrob Agents Chemother (2017) 0.75
Virulence evolution in a host-parasite system in the absence of viral evolution. Evol Ecol Res (2013) 0.75
Genome-wide screening identifies Plasmodium chabaudi-induced modifications of DNA methylation status of Tlr1 and Tlr6 gene promoters in liver, but not spleen, of female C57BL/6 mice. Parasitol Res (2013) 0.75
Variation in host resistance could limit the spread of more broadly virulent pathogens. Virulence (2013) 0.75
Eco-immunology and bioinvasion: revisiting the evolution of increased competitive ability hypotheses. Evol Appl (2016) 0.75
Bi-logistic model for disease dynamics caused by Mycobacterium tuberculosis in Russia. R Soc Open Sci (2017) 0.75
Reverse engineering field isolates of myxoma virus demonstrates that some gene disruptions or loss of function do not explain virulence changes observed in the field. J Virol (2017) 0.75
Multiplication rate variation in the human malaria parasite Plasmodium falciparum. Sci Rep (2017) 0.75
The economic and social burden of malaria. Nature (2002) 14.20
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10
The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg (2001) 11.74
The pathogenic basis of malaria. Nature (2002) 10.44
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell (1995) 10.35
Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell (1995) 9.31
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 9.31
Models of parasite virulence. Q Rev Biol (1996) 8.53
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg (1987) 6.58
Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature (1992) 6.42
Maternal antibodies block malaria. Nature (1998) 5.67
Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review. Trans R Soc Trop Med Hyg (2000) 5.45
Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature (1965) 5.45
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med (1998) 5.41
P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature (1997) 4.84
Imperfect vaccines and the evolution of pathogen virulence. Nature (2001) 4.74
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Immunization against blood-stage rodent malaria using purified parasite antigens. Nature (1981) 4.40
The ecology of genetically diverse infections. Science (2001) 4.37
Factors determining the true reservoir of infection of Plasmodium falciparum and Wuchereria bancrofti in a West African village. Trans R Soc Trop Med Hyg (1954) 4.33
Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends Microbiol (2003) 4.20
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis (2002) 4.14
Antigenic variation at the infected red cell surface in malaria. Annu Rev Microbiol (2001) 4.12
Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg (1997) 3.92
Why do some African children develop severe malaria? Parasitol Today (1991) 3.88
Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science (1986) 3.47
Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell (1997) 3.35
Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun (1995) 3.20
Malaria mortality rates in South Asia and in Africa: implications for malaria control. Parasitol Today (1998) 3.17
Virulence and local adaptation of a horizontally transmitted parasite. Science (1994) 3.14
Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest (1990) 3.04
Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood (1986) 3.00
Developmental selection of var gene expression in Plasmodium falciparum. Nature (1998) 2.96
Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol (1997) 2.91
Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest (1987) 2.91
Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol (1994) 2.91
Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc Natl Acad Sci U S A (1996) 2.89
Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 2.89
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci U S A (1983) 2.84
Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg (1991) 2.76
Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen. J Exp Med (1983) 2.76
Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg (1999) 2.76
Does multiple infection select for raised virulence? Trends Microbiol (2002) 2.75
Population structure and the evolution of virulence in nematode parasites of fig wasps. Science (1993) 2.71
Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am J Trop Med Hyg (1955) 2.71
Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology (2002) 2.67
Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun (1999) 2.62
Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull World Health Organ (1976) 2.56
Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature (1980) 2.55
Progress and challenges for malaria vaccines. Nature (2002) 2.50
A rhoptry-protein-associated mechanism of clonal phenotypic variation in rodent malaria. Nature (1999) 2.48
Cross-species interactions between malaria parasites in humans. Science (2000) 2.43
Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. J Immunol (2002) 2.39
Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol (1992) 2.38
Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect Immun (1999) 2.37
The regulation of malaria parasitaemia: parameter estimates for a population model. Parasitology (1995) 2.36
Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. J Infect Dis (2000) 2.35
A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Am J Trop Med Hyg (1999) 2.35
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A (2001) 2.27
Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect Immun (1982) 2.27
Rosetting: a new cytoadherence property of malaria-infected erythrocytes. Am J Trop Med Hyg (1988) 2.26
Virulence and pathogenesis. Trends Microbiol (2002) 2.19
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood (2002) 2.19
Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood (1991) 2.18
A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet (1997) 2.17
Why is the effect of malaria parasites on mosquito survival still unresolved? Trends Parasitol (2002) 2.16
Antigenic variation in Plasmodium falciparum. Proc Natl Acad Sci U S A (1991) 2.13
Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull World Health Organ (1966) 2.13
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11
Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect Immun (1983) 2.10
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg (1982) 2.06
Virulence evolution in a virus obeys a trade-off. Proc Biol Sci (1999) 2.06
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06
Parasite multiplication potential and the severity of Falciparum malaria. J Infect Dis (2000) 2.00
Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immun (2002) 2.00
Plasmodium vivax blood-stage dynamics. J Parasitol (2002) 1.99
Distribution of mature trophozoites and schizonts of Plasmodium falciparum in the organs of Aotus trivirgatus, the night monkey. Am J Trop Med Hyg (1969) 1.97
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol (2002) 1.95
Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Trans R Soc Trop Med Hyg (1999) 1.95
Diversity of antigens expressed on the surface of erythrocytes infected with mature Plasmodium falciparum parasites in Papua New Guinea. Am J Trop Med Hyg (1989) 1.94
Current status of malaria and potential for control. Clin Microbiol Rev (2001) 1.92
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol Lett (2000) 1.89
Epidemiological consequences of the mechanical transmission of myxomatosis by mosquitoes. J Hyg (Lond) (1956) 1.89
Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology (1988) 1.89
A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature (2001) 1.89
Plasmodium falciparum malaria: association of knobs on the surface of infected erythrocytes with a histidine-rich protein and the erythrocyte skeleton. J Cell Biol (1984) 1.88
Genes necessary for expression of a virulence determinant and for transmission of Plasmodium falciparum are located on a 0.3-megabase region of chromosome 9. Proc Natl Acad Sci U S A (1993) 1.88
Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg (1999) 1.83
Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol (1998) 1.81
Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg (1998) 1.80
Molecular mechanisms of cytoadherence in malaria. Am J Physiol (1999) 1.77
Plasmodium falciparum: effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cells. Exp Parasitol (1983) 1.77
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg (2001) 1.75
Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi--a rodent malaria model. Parasite Immunol (1990) 1.74
Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science (2007) 4.41
Fungal pathogen reduces potential for malaria transmission. Science (2005) 4.28
Understanding the link between malaria risk and climate. Proc Natl Acad Sci U S A (2009) 3.42
Decomposing health: tolerance and resistance to parasites in animals. Philos Trans R Soc Lond B Biol Sci (2009) 3.40
Maternal transfer of strain-specific immunity in an invertebrate. Curr Biol (2003) 3.19
Influence of climate on malaria transmission depends on daily temperature variation. Proc Natl Acad Sci U S A (2010) 3.16
Can fungal biopesticides control malaria? Nat Rev Microbiol (2007) 2.93
Virulence and competitive ability in genetically diverse malaria infections. Proc Natl Acad Sci U S A (2005) 2.85
Why is the effect of malaria parasites on mosquito survival still unresolved? Trends Parasitol (2002) 2.16
Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc Natl Acad Sci U S A (2007) 2.14
Insecticide control of vector-borne diseases: when is insecticide resistance a problem? PLoS Pathog (2010) 2.05
Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success. Evolution (2006) 2.02
Host-parasite and genotype-by-environment interactions: temperature modifies potential for selection by a sterilizing pathogen. Evolution (2005) 1.84
Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathog (2013) 1.77
Dynamics of multiple infection and within-host competition in genetically diverse malaria infections. Am Nat (2005) 1.74
Immunity promotes virulence evolution in a malaria model. PLoS Biol (2004) 1.69
Malaria-filaria coinfection in mice makes malarial disease more severe unless filarial infection achieves patency. J Infect Dis (2004) 1.63
Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: technique validation and applications. Mol Biochem Parasitol (2003) 1.62
The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol (2012) 1.61
Invertebrate immunity and the limits of mechanistic immunology. Nat Immunol (2005) 1.57
The role of immune-mediated apparent competition in genetically diverse malaria infections. Am Nat (2006) 1.56
Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat Rev Microbiol (2010) 1.50
Probabilistic order in antigenic variation of Trypanosoma brucei. Int J Parasitol (2005) 1.49
Host cell preference and variable transmission strategies in malaria parasites. Proc Biol Sci (2005) 1.44
Poor maternal environment enhances offspring disease resistance in an invertebrate. Proc Biol Sci (2005) 1.43
Parasite-intrinsic factors can explain ordered progression of trypanosome antigenic variation. Proc Natl Acad Sci U S A (2007) 1.43
Malaria in India: the center for the study of complex malaria in India. Acta Trop (2011) 1.42
Thermal behaviour of Anopheles stephensi in response to infection with malaria and fungal entomopathogens. Malar J (2009) 1.38
Lessons from agriculture for the sustainable management of malaria vectors. PLoS Med (2012) 1.34
Lethal and pre-lethal effects of a fungal biopesticide contribute to substantial and rapid control of malaria vectors. PLoS One (2011) 1.34
Complex effects of temperature on mosquito immune function. Proc Biol Sci (2012) 1.31
Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections. Proc Biol Sci (2004) 1.30
Understanding and predicting strain-specific patterns of pathogenesis in the rodent malaria Plasmodium chabaudi. Am Nat (2008) 1.29
Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution (2010) 1.27
Evolution of parasite virulence when host responses cause disease. Proc Biol Sci (2007) 1.26
Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar J (2004) 1.25
Transmission stage investment of malaria parasites in response to in-host competition. Proc Biol Sci (2007) 1.25
Fertility insurance and the sex ratios of malaria and related hemospororin blood parasites. J Parasitol (2002) 1.24
Evolutionary history and attenuation of myxoma virus on two continents. PLoS Pathog (2012) 1.22
The effect of parental rearing conditions on offspring life history in Anopheles stephensi. Malar J (2007) 1.22
Rethinking vector immunology: the role of environmental temperature in shaping resistance. Nat Rev Microbiol (2012) 1.20
Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy. PLoS Biol (2010) 1.19
Real-time quantitative PCR for analysis of candidate fungal biopesticides against malaria: technique validation and first applications. J Invertebr Pathol (2009) 1.19
The effect of temperature on Anopheles mosquito population dynamics and the potential for malaria transmission. PLoS One (2013) 1.17
Inbreeding and parasite sex ratios. Proc Biol Sci (2002) 1.16
Quantitative analysis of immune response and erythropoiesis during rodent malarial infection. PLoS Comput Biol (2010) 1.16
The effects of age, exposure history and malaria infection on the susceptibility of Anopheles mosquitoes to low concentrations of pyrethroid. PLoS One (2011) 1.16
Does the drug sensitivity of malaria parasites depend on their virulence? Malar J (2008) 1.11
Characterizing microclimate in urban malaria transmission settings: a case study from Chennai, India. Malar J (2013) 1.11
Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture. Evolution (2012) 1.06
Do malaria parasites manipulate mosquitoes? Trends Parasitol (2012) 1.06
Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites. BMC Evol Biol (2008) 1.04
Reduction in host-finding behaviour in fungus-infected mosquitoes is correlated with reduction in olfactory receptor neuron responsiveness. Malar J (2011) 1.02
Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria. PLoS One (2012) 1.01
Mosquito appetite for blood is stimulated by Plasmodium chabaudi infections in themselves and their vertebrate hosts. Malar J (2004) 1.01
'Manipulation' without the parasite: altered feeding behaviour of mosquitoes is not dependent on infection with malaria parasites. Proc Biol Sci (2013) 1.01
Plasmodium chabaudi: reverse transcription PCR for the detection and quantification of transmission stage malaria parasites. Exp Parasitol (2005) 1.00
Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread. J Virol (2013) 0.96
Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi. Proc Biol Sci (2012) 0.94
Mixed allele malaria vaccines: host protection and within-host selection. Vaccine (2008) 0.94
CD4+T cells do not mediate within-host competition between genetically diverse malaria parasites. Proc Biol Sci (2008) 0.92
Ahead of the curve: next generation estimators of drug resistance in malaria infections. Trends Parasitol (2013) 0.92
Modelling Marek's disease virus (MDV) infection: parameter estimates for mortality rate and infectiousness. BMC Vet Res (2011) 0.90
Alterations in mosquito behaviour by malaria parasites: potential impact on force of infection. Malar J (2014) 0.90
Bridging scales in the evolution of infectious disease life histories: application. Evolution (2011) 0.90
Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci (2010) 0.89
Modelling malaria pathogenesis. Cell Microbiol (2008) 0.89
Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. Int J Parasitol (2007) 0.88
Prospective malaria control using entomopathogenic fungi: comparative evaluation of impact on transmission and selection for resistance. Malar J (2012) 0.88
Environmental temperatures significantly change the impact of insecticides measured using WHOPES protocols. Malar J (2014) 0.86
Toxoplasma gondii, sex and premature rejection. Trends Parasitol (2003) 0.86
The effectiveness of mass vaccination on Marek's disease virus (MDV) outbreaks and detection within a broiler barn: a modeling study. Epidemics (2013) 0.85
Synchrony in malaria infections: how intensifying within-host competition can be adaptive. Am Nat (2013) 0.85
Storage and persistence of a candidate fungal biopesticide for use against adult malaria vectors. Malar J (2012) 0.85
Antibiotic resistance: a primer and call to action. Health Commun (2014) 0.84
The impact of immunization on competition within Plasmodium infections. Evolution (2008) 0.84
Relationship between levels of very virulent MDV in poultry dust and in feather tips from vaccinated chickens. Avian Dis (2013) 0.83
Rodent malaria parasites Plasmodium chabaudi and P. vinckei do not increase their rates of gametocytogenesis in response to mosquito probing. Proc Biol Sci (2005) 0.82
The presence of Plasmodium falciparum gametocytes in human blood increases the gravidity of Anopheles gambiae mosquitoes. Am J Trop Med Hyg (2005) 0.81
Bridging taxonomic and disciplinary divides in infectious disease. Ecohealth (2011) 0.80
Mosquito transmission, growth phenotypes and the virulence of malaria parasites. Malar J (2013) 0.80
How will public and animal health interventions drive life-history evolution in parasitic nematodes? Parasitology (2008) 0.80
Fungal bioinsecticide with a sting. Nat Biotechnol (2007) 0.80
Most of the response elicited against Wolbachia surface protein in filarial nematode infection is due to the infective larval stage. J Infect Dis (2003) 0.79
Evaluating the lethal and pre-lethal effects of a range of fungi against adult Anopheles stephensi mosquitoes. Malar J (2012) 0.79
Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi. Infect Genet Evol (2013) 0.79
Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. PLoS Pathog (2010) 0.79
The effect of immunodeficiency on the evolution of virulence: an experimental test with the rodent malaria Plasmodium chabaudi. Am Nat (2014) 0.78
Litomosoides sigmodontis: vaccine-induced immune responses against Wolbachia surface protein can enhance the survival of filarial nematodes during primary infection. Exp Parasitol (2007) 0.78
Malaria: The vector as protector. Nature (2013) 0.75
So what if parasites vary? Trends Parasitol (2002) 0.75
The past 20 years of ecology and evolution. Trends Ecol Evol (2006) 0.75
The expanding field of evolutionary immunology: 'the impact of the environment on innate immunity: at the defence frontier - the biology of innate immunity'. Expert Rev Clin Immunol (2007) 0.75
The next 20 years of ecology and evolution. Trends Ecol Evol (2006) 0.75